Skip to main content

Table 2 MiR-182-5p expression in NSCLC data from RT-qPCR

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

Clinicopathological parametersnRelevant expression of miR-182-5p (2−ΔCq)
Mean ± SDt/F-valuep-value
TissueNSCLC12429.615 ± 5.61613.979< 0.001*
Noncancerous12422.859 ± 3.669
GenderMale7430.144 ± 5.4971.2780.204
Female5028.833 ± 5.755
Age (years)< 605630.913 ± 5.0522.4130.017*
≥606828.547 ± 5.864
SmokeNo3831.184 ± 5.1850.7200.474
Yes2930.237 ± 5.530
Histological typeAdenocarcinoma10129.337 ± 5.717−1.2450.221
Squamous carcinoma2330.836 ± 5.086
Tumor size≤3 cm6024.995 ± 4.570−14.353< 0.001*
> 3 cm6433.947 ± 1.620
Vascular invasionNo9029.456 ± 5.720−0.5120.609
Yes3430.037 ± 5.391
TNMI-II5427.131 ± 5.424−4.632< 0.001*
III-IV7031.532 ± 5.007
Lymph node metastasisNo5626.621 ± 5.128−6.095< 0.001*
Yes6832.081 ± 4.759
Pathological gradingI1727.642 ± 5.8631.246a0.291
II7729.853 ± 5.721
III3030.124 ± 5.131
  1. NSCLC: non-small cell lung cancer; SD: standard deviation
  2. a One-way analysis of variance (ANOVA) was performed
  3. * The results were statistically significant (P < 0.05)